Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062564) titled 'A prospective single-center observational study evaluating the patient experience and impact on the persistence of nerandomilast treatment in a patient support program for patients with interstitial lung disease: "Ashita Assist"' on Aug. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Social Medical Corporation St. Francis Society Himeji St. Mary's Hospital
Condition:
Condition - Adult patients with interstitial lung disease at Himeji St. Mary's Hospital who are newly initiated on nerandomilast, switched from nintedanib to nerandomilast, or have nerandomilast added to nintedanib, and who are newly regis...